Global Hormone Replacement Therapy Market Analysis, Trends, Share, Size, Growth, Opportunity & Forecast 2018-2023, With an Expected CAGR of 7.2% - ResearchAndMarkets.com

DUBLIN--()--The "Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.

The market value is projected to exceed US$ 5.9 Billion by 2023, expanding at a CAGR of 7.2% during 2018-2023.

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells. The global hormone replacement therapy market reached a value of US$ 3.9 Billion in 2017.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for HRT. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market.

Companies Mentioned

  • Abbott
  • Bayer AG
  • Eli Lilly & Company
  • Roche
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck
  • Mylan NV
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Hormone Replacement Therapy Market

6 Market Breakup by Product

7 Market Breakup by Route of Administration

8 Market Breakup by Type of Disease

9 Market Breakup by Region

10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/6xfrpr/global_hormone?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Sexual and Reproductive Health Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Sexual and Reproductive Health Drugs